February 12th 2025
The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral solution.
Multidisciplinary Care Emphasized for Pregnant Women With SMA
New Imaging Approach May Assess Disease Burden in Patients With SMA
Analysis of Nusinersen Shows Favorable Safety Profile in Adults With SMA